Genetic code expansion (GCE) breaks the constraints of the 20 standard amino acids by enabling the site-specific incorporation of non-canonical amino acids (ncAAs). This powerful technology allows for precise protein engineering, including the direct enhancement of protein stability. Leveraging our proprietary GCEngine platform, we empower researchers to overcome inherent limitations of natural proteins, such as thermal instability and protease susceptibility. As a trusted partner in next-generation GCE, we provide comprehensive solutions, from orthogonal pair development to in vivo application, ensuring your therapeutic or industrial proteins achieve superior robustness and performance.
Overview of Stability-Enhancing ncAA Incorporation
Protein instability, manifesting as aggregation, misfolding, or enzymatic degradation, remains a critical bottleneck in developing effective biologics, industrial enzymes, and research reagents. Stability-enhancing ncAA incorporation utilizes engineered orthogonal aaRS/tRNA pairs to site-specifically insert synthetic amino acid analogs into a polypeptide chain. These ncAAs are designed to reinforce the protein scaffold through mechanisms such as enhanced hydrophobic packing, additional hydrogen bonding networks, or the introduction of conformationally constrained side chains. Compared to traditional random mutagenesis approaches, this targeted strategy enables the direct introduction of stabilizing elements, often leading to improved thermodynamic and kinetic stability with minimal disruption to the native protein fold.
Fig.1 Enhancing the thermal stability of enzymes through ncAA incorporation. (Lugtenburg T, et al., 2023)
Advantages of Stability-Enhancing ncAA Incorporation
- Enhanced Thermal Stability: Introducing ncAAs with fluorinated, bulky hydrophobic, or cross-linking side chains can significantly increase the protein's melting temperature (Tm).
- Increased Proteolytic Resistance: Selective incorporation of protease-resistant motifs can shield specific cleavage sites, extending functional half-life in complex biological environments.
- Precision Engineering: Site-specific modification allows for the strategic stabilization of vulnerable regions (e.g., flexible loops) without compromising the protein's core biological activity.
- Improved Pharmacokinetic Properties: For therapeutics, incorporating ncAAs that modulate hydrophobicity, introducing site-specific PEGylation mimics, or reducing immunogenic epitope recognition can enhance circulation time and efficacy.
Applications of Stability-Enhancing ncAA Incorporation
| Application Area |
Description |
| Biotherapeutics |
Develop long-acting protein drugs, antibodies, and enzyme therapeutics with enhanced serum stability and reduced immunogenicity. |
| Enzyme Engineering |
Create robust biocatalysts that maintain high activity under demanding industrial conditions (e.g., extreme pH, high temperature, organic solvents). |
| Advanced Biomaterials |
Fabricate engineered peptides and proteins that self-assemble into stable nanostructures, hydrogels, or materials with superior mechanical and enzymatic resistance. |
| Structural Biology |
Stabilizing flexible or disordered protein regions to facilitate high-resolution crystallization or Cryo-EM imaging. |
Our Services
Driven by a high-throughput orthogonal aaRS/tRNA pair development engine, our GCEngine platform offers an end-to-end pipeline for stabilizing your target proteins. Our service encompasses vector construction, host system optimization (including E. coli, yeast, and mammalian platforms), and rigorous protein analytical validation, ensuring a seamless workflow from concept to production of your stabilized protein of interest.
Workflow of Stability-Enhancing ncAA Incorporation
- Consultation & Design: Initiating with a detailed consultation to analyze your protein's sequence, structure, and stability bottlenecks. We then collaboratively define the primary goal (e.g., thermal resilience, protease resistance, shelf-life extension) and select the most effective class of stability-enhancing ncAAs and optimal incorporation sites.
- Orthogonal Pair Development & Screening: Using our proprietary platform, we engineer and screen tailored libraries of orthogonal aaRS/tRNA pairs to identify the most efficient and specific system for your chosen ncAA.
- In Vitro Validation: The selected system is first validated in a cell-free expression system or microbial hosts to confirm high-fidelity ncAA incorporation and assess initial stability improvements.
- In Vivo Application & Expression: The optimized system is deployed in the desired production host (e.g., E. coli, yeast, mammalian cells) for scalable synthesis of the stabilized target protein.
- Purification & Comprehensive Characterization: The protein is purified, and ncAA incorporation is verified via high-resolution mass spectrometry. Stability enhancement is quantified through thermal shift assays, protease challenge tests, and long-term functional stability studies.
Types of Stability-Enhancing ncAAs
We offer expertise in the site-specific incorporation of a diverse and mechanistically distinct repertoire of ncAAs, each engineered to address specific biophysical challenges. These synthetic building blocks are categorized by their primary mode of action, enabling targeted enhancement of proteolytic resistance, thermodynamic stability, and functional longevity.
Side-Chain Engineered ncAAs
Strategic integration of ncAAs with modified side chains enhances stability through optimized non-covalent interactions. Advanced fluorinated amino acids utilizing the fluorous effect, introduce hyper-hydrophobic clusters that increase core packing efficiency and thermal robustness. Additionally, the use of ncAAs with rigid bicyclic or bulky aromatic side chains restricts local conformational entropy, effectively "filling" internal cavities to stabilize the folded state against organic solvents and heat.
Charged or Polar ncAAs
Incorporation of ncAAs with novel polar or charged side chains, such as sulfonated residues or elongated alkyl-linked carboxylates, enables the engineering of precise surface charge distributions. This approach is specifically leveraged to create de novo intramolecular salt bridges or to enhance the hydration shell of the protein. Such modifications significantly improve solubility profiles and prevent aggregation under high-concentration formulations or extreme pH conditions.
Why Partner with Us?
- Proprietary Integrated Platform: Accessing a proprietary GCEngine platform featuring high-throughput orthogonal pair screening and versatile multi-host expression systems, enabling efficient and scalable development of stabilized proteins.
- Tailored, End-to-End Partnership: Receiving a customized solution tailored to your specific protein, stability challenge, and application goals, supported by a collaborative partnership from initial design to final delivery.
- Cross-Disciplinary Expertise: Drawing upon deep, specialized expertise from a team with extensive experience in both synthetic biology and industrial protein engineering, we ensure scientifically sound and pragmatic solutions.
- Guaranteed Quality & Reproducibility: Guaranteeing high-quality, reproducible outcomes through rigorous, multi-tiered analytical validation and established protocols for consistent, scalable production.
Contact Us
Partnering with us provides access to an advanced GCEngine platform that accelerates the development of stabilized protein therapeutics, biocatalysts, and research tools. Our unique combination of proprietary orthogonal pair development, multi-host expression expertise, and structure-guided design ensures you receive a scientifically robust and application-ready solution. To learn more about how our stability-enhancing ncAA incorporation can elevate your research, please contact us.
Reference
- Lugtenburg, Tim et al. "Non-canonical amino acids as a tool for the thermal stabilization of enzymes." Protein engineering, design & selection: PEDS 36 (2023): gzad003.
All our services are exclusively intended for preclinical research purposes. They are not intended for diagnostic, therapeutic, or patient management applications.
